{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:49:43Z","timestamp":1789202983534,"version":"build-2803163510"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.cca.2015.10.021","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T20:02:28Z","timestamp":1446494548000},"page":"66-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["HDL\u2014A molecule with a multi-faceted role in coronary artery disease"],"prefix":"10.1016","volume":"452","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-1099","authenticated-orcid":false,"given":"Sarika","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajeet K.","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetika","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cca.2015.10.021_bb0005","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1440-1681.2010.05380.x","article-title":"Antioxidant properties of high density lipoprotein and atherosclerosis","volume":"37","author":"Podrez","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cca.2015.10.021_bb0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1194\/jlr.M500531-JLR200","article-title":"Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I","volume":"47","author":"Duong","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0015","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M704590200","article-title":"Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles","volume":"282","author":"Vedhachalam","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cca.2015.10.021_bb0020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nsmb.2028","article-title":"Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma","volume":"18","author":"Huang","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-2275(20)32028-9","article-title":"Apolipoprotein A-I: structure\u2013function relationships","volume":"41","author":"Frank","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nat. Med."},{"issue":"28","key":"10.1016\/j.cca.2015.10.021_bb0035","doi-asserted-by":"crossref","first-page":"21262","DOI":"10.1074\/jbc.M002310200","article-title":"Binding of high density lipoprotein (HDL) and discoidal reeconstituted HDL to the HDL receptor scavenger receptor class B type 1. Effect of lipid association and ApoA-1 mutations on receptor binding","volume":"275","author":"Lidaki","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2015.10.021_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17584299.4.1.17","article-title":"Changing paradigm in HDL metabolism and cellular effects","volume":"4","author":"van Wijk","year":"2009","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/hh0302.104462","article-title":"Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice","volume":"90","author":"Braun","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0050","doi-asserted-by":"crossref","first-page":"12610","DOI":"10.1073\/pnas.94.23.12610","article-title":"A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism","volume":"94","author":"Rigotti","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.cca.2015.10.021_bb0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/clp.09.21","article-title":"Association of ApoE and HDL-C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy","volume":"4","author":"Moriarty","year":"2009","journal-title":"Clin. Lipidol."},{"issue":"12","key":"10.1016\/j.cca.2015.10.021_bb0060","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.0000013424.28206.8F","article-title":"High-density lipoprotein restores endothelial function in hypercholesterolemic men","volume":"105","author":"Spieker","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2015.10.021_bb0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/bbrc.2000.2265","article-title":"Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits","volume":"269","author":"Mackness","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.10.021_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/ATVBAHA.108.179317","article-title":"Proteomics of apolipoproteins and associated proteins from plasma high density lipoproteins","volume":"30","author":"Davidsson","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2153-0637.1000133","article-title":"Lipidomics of plasma high density lipoprotein: insights into anti-atherogenic function","volume":"5","author":"Kontush","year":"2015","journal-title":"J. Glycomics Lipidomics"},{"key":"10.1016\/j.cca.2015.10.021_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: particle subclasses and molecular components","volume":"224","author":"Kontush","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.cca.2015.10.021_bb0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1042\/bj1040340","article-title":"Lipid composition of human serum lipoproteins","volume":"104","author":"Skipski","year":"1967","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2015.10.021_bb0090","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.107.145672","article-title":"Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to anti-apoptotic and anti-oxidative activities","volume":"27","author":"Kontush","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0100","first-page":"68","article-title":"Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry","volume":"2011","author":"Scherer","year":"1811","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2015.10.021_bb0105","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.chroma.2010.01.006","article-title":"Profiling of phospholipids in lipoproteins by multiplexed hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry","volume":"1217","author":"Lee","year":"2010","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2015.10.021_bb0110","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1073\/pnas.97.4.1743","article-title":"Cardiolipin is a normal component of human plasma lipoproteins","volume":"97","author":"Deguchi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.10.021_bb0115","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.M006494","article-title":"Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol","volume":"51","author":"Yetukuri","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0120","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein. A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cca.2015.10.021_bb0130","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/pmic.200401233","article-title":"Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins","volume":"5","author":"Heller","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.cca.2015.10.021_bb0135","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pmic.200401010","article-title":"Lipoproteomics II. Mapping of proteins in high density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry","volume":"5","author":"Karlsson","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.cca.2015.10.021_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/pmic.200500191","article-title":"Proteomic analysis of high-density lipoprotein","volume":"6","author":"Rezaee","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.cca.2015.10.021_bb0145","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbrc.2005.12.098","article-title":"Diverse range of small peptides associated with high-density lipoprotein","volume":"340","author":"Hortin","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cca.2015.10.021_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17584299.4.1.17","article-title":"Changing paradigm in HDL metabolism and cellular effects","volume":"4","author":"Van Wijk","year":"2009","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0021-9150(01)00447-6","article-title":"The impact of phospholipid transfer protein (PLTP) on HDL metabolism","volume":"155","author":"Huuskonen","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2015.10.021_bb0165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0170","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1373\/clinchem.2007.101923","article-title":"Laboratory assessment of HDL heterogeneity and function","volume":"54","author":"Movva","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0175","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1742-1241.2007.01509.x","article-title":"HDL-C is a powerful lipid predictor of cardiovascular diseases","volume":"61","author":"Bruckert","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.cca.2015.10.021_bb0180","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.110.984120","article-title":"The complexity of high-density lipoproteins","volume":"122","author":"Fogelman","year":"2010","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.cca.2015.10.021_bb0185","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2015.10.021_bb0190","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","article-title":"Nature's randomised trials","volume":"366","author":"Hingorani","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2015.10.021_bb0195","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(12)60481-4","article-title":"Mendelian randomisation, lipids, and cardiovascular disease","volume":"380","author":"Harrison","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2015.10.021_bb0200","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2015.10.021_bb0205","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1194\/jlr.R024075","article-title":"Cholesteryl ester transfer protein (CETP) inhibition as a strategy to reduce cardiovascular risk","volume":"53","author":"Barter","year":"2012","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.cca.2015.10.021_bb0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrcardio.2009.94","article-title":"Update on strategies to increase HDL quantity and function","volume":"6","author":"Duffy","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"issue":"23","key":"10.1016\/j.cca.2015.10.021_bb0215","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2012.02.021","article-title":"The AIM-HIGH (atherothrombosis intervention in metabolic syndrome with low HDL\/high triglycerides: impact on global health outcomes) TrialTo believe or not to believe?","volume":"59","author":"Nicolls","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2015.10.021_bb0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3909\/ricm0565","article-title":"Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?","volume":"12","author":"Shah","year":"2011","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb0225","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1194\/jlr.R800036-JLR200","article-title":"The role of dysfunctional HDL in atherosclerosis","volume":"50 (Suppl.)","author":"Navab","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5551\/jat.E571","article-title":"Anti-atherogenic functionality of high density lipoprotein: how much versus how good","volume":"15","author":"Sviridov","year":"2008","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.cca.2015.10.021_bb0235","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1073\/pnas.89.21.10316","article-title":"High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors","volume":"89","author":"Bowry","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.10.021_bb0240","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0022-2275(20)33461-1","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1","volume":"41","author":"Navab","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","article-title":"The paradox of dysfunctional high-density lipoprotein","volume":"18","author":"Ansell","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0250","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M800607-JLR200","article-title":"HDL is the major lipoprotein carrier of plasma F2-isoprostanes","volume":"50","author":"Proudfoot","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0255","doi-asserted-by":"crossref","first-page":"38503","DOI":"10.1074\/jbc.M203318200","article-title":"Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36","volume":"277","author":"Podrez","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2015.10.021_bb0260","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1538-7836.2009.03422.x","article-title":"Platelet hyperreactivity, scavenger receptors and atherothrombosis","volume":"7","author":"Valiyaveettil","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cca.2015.10.021_bb0265","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1182\/blood-2007-08-107813","article-title":"Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI","volume":"111","author":"Valiyaveettil","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cca.2015.10.021_bb0270","first-page":"253","article-title":"Oxidative modification of LDL in atherothrombosis","volume":"53","author":"Holvoet","year":"1998","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.cca.2015.10.021_bb0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0925-4439(97)00091-4","article-title":"Non-conventional modification of LDL: chemical models for macrophage recognition of oxidized LDL","volume":"1362","author":"Hoppe","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2015.10.021_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0891-5849(87)90040-2","article-title":"Free radical modification of low-density lipoprotein: mechanisms and biological consequences","volume":"3","author":"Heinecke","year":"1987","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.08.008","article-title":"Structural modifications of HDL and functional consequences","volume":"184","author":"Ferretti","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2015.10.021_bb0290","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.10.021_bb0295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0300","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Anti-inflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0305","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2015.10.021_bb0310","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1152\/physrev.00005.2003","article-title":"Role of monocytes in atherogenesis","volume":"83","author":"Osterud","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cca.2015.10.021_bb0315","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/circ.105.1.2","article-title":"On evolutionary biology, inflammation, infection, and the causes of atherosclerosis","volume":"105","author":"Ridker","year":"2002","journal-title":"Circulation"},{"issue":"Suppl. 6A","key":"10.1016\/j.cca.2015.10.021_bb0320","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/j.amjmed.2004.02.006","article-title":"Inflammation and atherosclerosis: role of C-reactive protein in risk assessment","volume":"116","author":"Libby","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb0325","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0330","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI5710","article-title":"Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta integrin","volume":"103","author":"Shih","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0335","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V76.5.965.965","article-title":"Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells","volume":"76","author":"Carlos","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cca.2015.10.021_bb0340","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","article-title":"Adhesion molecules and atherosclerosis","volume":"170","author":"Blankenberg","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2015.10.021_bb0345","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.93.4.672","article-title":"Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content","volume":"93","author":"O'Brien","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0350","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1172\/JCI115532","article-title":"Monocyte transmigration induced by modification of low density lipoprotein in co-cultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein","volume":"88","author":"Navab","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0355","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0021-9150(00)00437-8","article-title":"Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression","volume":"154","author":"Ashby","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2015.10.021_bb0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/bbrc.1997.7236","article-title":"Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins","volume":"238","author":"Calabresi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.10.021_bb0370","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1357-2725(02)00173-5","article-title":"Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression","volume":"35","author":"Park","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0375","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0380","doi-asserted-by":"crossref","first-page":"33143","DOI":"10.1074\/jbc.274.46.33143","article-title":"High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL","volume":"274","author":"Xia","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0385","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.ATV.18.9.1450","article-title":"Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells","volume":"18","author":"Ashby","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.cca.2015.10.021_bb0390","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00041433-200206000-00008","article-title":"Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells","volume":"13","author":"Barter","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0395","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1096\/fj.02-0240fje","article-title":"HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappa B activation in smooth muscle cells","volume":"17","author":"Robbesyn","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2015.10.021_bb0400","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/01.ATV.19.4.910","article-title":"High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2","volume":"19","author":"Cockerill","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0405","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2004.04.056","article-title":"Paraoxonase-1 inhibits oxidized LDL-induced MCP-1 production by endothelial cells","volume":"318","author":"Mackness","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.10.021_bb0410","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/hc4501.098952","article-title":"Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content","volume":"104","author":"Rong","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0415","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1161\/01.CIR.0000127419.45975.26","article-title":"High-density lipoproteins neutralize C-reactive protein inflammatory activity","volume":"109","author":"Wadham","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0420","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/496925","article-title":"The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer","volume":"2011","author":"McGrowder","year":"2011","journal-title":"Cholesterol"},{"key":"10.1016\/j.cca.2015.10.021_bb0425","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0430","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.jacc.2005.06.080","article-title":"High-density lipoprotein function recent advances","volume":"46","author":"Ansell","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2015.10.021_bb0435","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1096\/fj.11-191593","article-title":"Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism","volume":"26","author":"Blache","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2015.10.021_bb0440","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MOL.0b013e32834701de","article-title":"HDL scavenger receptor class B type I and platelet function","volume":"22","author":"Nofer","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0445","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.ATV.19.2.378","article-title":"Inhibition of arterial thrombus formation by ApoA1 Milano","volume":"19","author":"Li","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0450","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI5006","article-title":"High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C","volume":"103","author":"Griffin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0455","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1136\/hrt.2010.217273","article-title":"Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis","volume":"97","author":"Natorska","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.cca.2015.10.021_bb0460","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0008-6363(99)00150-9","article-title":"Lipids and the endothelium","volume":"43","author":"Dart","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0465","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0022-2275(20)31582-0","article-title":"A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids","volume":"42","author":"Navab","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0470","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0022-2275(20)33462-3","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3","volume":"41","author":"Navab","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0475","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2006.04.080","article-title":"Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function","volume":"48","author":"Nicholls","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2015.10.021_bb0480","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11892-008-0010-5","article-title":"Why is HDL functionally deficient in type 2 diabetes?","volume":"8","author":"Kontush","year":"2008","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cca.2015.10.021_bb0490","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/ATVBAHA.108.179226","article-title":"Dysfunctional HDL as a diagnostic and therapeutic target","volume":"30","author":"Smith","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0495","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high density lipoprotein particle size, and apo-lipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2015.10.021_bb0500","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.704031","article-title":"Apolipoprotein A-II is inversely associated with risk of future coronary artery disease","volume":"116","author":"Birjmohun","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0505","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1074\/jbc.273.11.6088","article-title":"Oxidation of high density lipoproteins II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII","volume":"273","author":"Garner","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0510","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis","volume":"29","author":"Zerrad-Saadi","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0515","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1073\/pnas.91.20.9607","article-title":"Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse","volume":"91","author":"Plump","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.10.021_bb0520","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI117412","article-title":"Apolipoprotein AI trans-gene corrects apolipoprotein E deficiency-induced atherosclerosis in mice","volume":"94","author":"P\u00e1szty","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0525","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1568-9972(01)00018-0","article-title":"High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic Inflammation?","volume":"1","author":"Burger","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2015.10.021_bb0530","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"116","author":"Rader","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0535","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant apoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2015.10.021_bb0540","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0b013e32832ac051","article-title":"Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action","volume":"20","author":"Getz","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0545","article-title":"Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?","volume":"143","author":"Vuilleumier","year":"2013","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.cca.2015.10.021_bb0550","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0022-2275(20)30115-2","article-title":"Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II","volume":"43","author":"Boisfer","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0555","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1161\/01.ATV.0000175760.28378.80","article-title":"Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage specific reverse cholesterol transport in vivo","volume":"25","author":"Rotllan","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0560","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-2275(20)33906-7","article-title":"Human apolipoprotein A-II is a proatherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet","volume":"39","author":"Escola-Gil","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0565","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.8332912","article-title":"Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II","volume":"261","author":"Warden","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cca.2015.10.021_bb0570","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.ATV.0000152613.83243.12","article-title":"Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels","volume":"25","author":"Raffai","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0575","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1074\/jbc.M003324200","article-title":"Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E","volume":"276","author":"Tangirala","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0580","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1161\/01.ATV.20.8.1939","article-title":"Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice","volume":"20","author":"Thorngate","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0585","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2015.10.021_bb0590","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nbd.2005.05.002","article-title":"Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade","volume":"20","author":"Ophir","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cca.2015.10.021_bb0595","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-5793(03)00261-8","article-title":"Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells","volume":"540","author":"Sacre","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2015.10.021_bb0600","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1172\/JCI119369","article-title":"Mildly oxidized LDL induces an increased apolipoprotein J\/paraoxonase ratio","volume":"99","author":"Navab","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0605","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.freeradbiomed.2004.10.038","article-title":"Differential effects of clusterin\/apolipoprotein J on cellular growth and survival","volume":"38","author":"Trougakos","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb0610","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.21.6.1023","article-title":"Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice","volume":"21","author":"Ostos","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0615","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.ATV.0000119353.03690.22","article-title":"Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide","volume":"24","author":"Recalde","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0620","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1172\/JCI200421233","article-title":"Apolipoprotein A-IV inhibits experimental colitis","volume":"114","author":"Vowinkel","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0625","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0021-9258(18)89547-3","article-title":"Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV","volume":"260","author":"Steinmetz","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0630","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1006\/bbrc.2000.4219","article-title":"Apolipoprotein specificity for lipid efflux by the human ABCAI transporter","volume":"280","author":"Remaley","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.10.021_bb0635","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0006-3002(62)90156-7","article-title":"The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase","volume":"65","author":"Glomset","year":"1962","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2015.10.021_bb0640","doi-asserted-by":"crossref","first-page":"16231","DOI":"10.1074\/jbc.272.26.16231","article-title":"Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation","volume":"272","author":"Goyal","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0645","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cca.2015.10.021_bb0650","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","article-title":"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice","volume":"106","author":"Tward","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0655","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.carpath.2007.10.001","article-title":"Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia","volume":"17","author":"Ng","year":"2008","journal-title":"Cardiovasc. Pathol."},{"issue":"8","key":"10.1016\/j.cca.2015.10.021_bb0660","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0665","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOL.0b013e32832ec141","article-title":"Variation in paraoxonase-1 activity and atherosclerosis","volume":"20","author":"Soran","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006809","article-title":"Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease: the EPIC-Norfolk Prospective Population Study","volume":"4","author":"Birjmohun","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2015.10.021_bb0675","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2015.10.021_bb0680","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0685","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1074\/jbc.M910376199","article-title":"Combined serum paraoxonase knockout\/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis","volume":"275","author":"Shih","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0690","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2004.10.028","article-title":"Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine","volume":"179","author":"Rosenblat","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2015.10.021_bb0695","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.clinbiochem.2006.05.010","article-title":"Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease","volume":"39","author":"Kerkeni","year":"2006","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2015.10.021_bb0700","doi-asserted-by":"crossref","first-page":"33435","DOI":"10.1074\/jbc.M004543200","article-title":"Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation","volume":"275","author":"Draganov","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0705","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","article-title":"Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids","volume":"21","author":"Reddy","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0710","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.RES.0000264499.48737.69","article-title":"Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice","volume":"100","author":"Shih","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0715","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mlc.2000.107692","article-title":"Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides","volume":"136","author":"Chen","year":"2000","journal-title":"J. Lab. Clin. Med."},{"issue":"17","key":"10.1016\/j.cca.2015.10.021_bb0720","first-page":"398","article-title":"Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase","volume":"262","author":"Maddipati","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0725","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2337\/diabetes.53.9.2455","article-title":"Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients","volume":"53","author":"Hamanishi","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2015.10.021_bb0730","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/07853890500330193","article-title":"Parameters of antioxidative defense in Type 2 diabetic patients with cardiovascular complications","volume":"37","author":"Colak","year":"2005","journal-title":"Ann. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb0735","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa030535","article-title":"Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease","volume":"349","author":"Blankenberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb0740","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00019501-200304000-00007","article-title":"Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease","volume":"14","author":"Winter","year":"2003","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.cca.2015.10.021_bb0745","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.97.19.1930","article-title":"Glutathione-related antioxidant defenses in human atherosclerotic plaques","volume":"97","author":"Lapenna","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0750","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.106.664250","article-title":"Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0755","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/01.ATV.0000258809.47285.07","article-title":"Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"Torzewski","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0760","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1194\/jlr.M500377-JLR200","article-title":"Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL\/J6 mice fed a high-fat diet","volume":"47","author":"de Haan","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0765","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.85.4.311","article-title":"Evidence that phospholipid oxidation products and\/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086","volume":"85","author":"Subbanagounder","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0770","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/S0021-9258(18)61335-3","article-title":"Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor","volume":"262","author":"Stafforini","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0775","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.freeradbiomed.2004.10.010","article-title":"Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite","volume":"38","author":"Connelly","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb0780","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1074\/jbc.M211126200","article-title":"Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles","volume":"278","author":"Marathe","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0785","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.ATV.0000067701.09398.18","article-title":"Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress","volume":"23","author":"Noto","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0790","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1096\/fj.99-1029com","article-title":"HDL-associated PAF-AH reduces endothelial adhesiveness in apoE\u2212\/\u2212 mice","volume":"14","author":"Theilmeier","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2015.10.021_bb0795","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/01.CIR.103.20.2495","article-title":"Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice","volume":"103","author":"Quarck","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0800","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1161\/CIRCULATIONAHA.104.476242","volume":"111","author":"Arakawa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0805","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1194\/jlr.R800024-JLR200","article-title":"The emerging roles of PAF acetylhydrolase","volume":"50 (Suppl.)","author":"McIntyre","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0810","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.108.771899","article-title":"Integrated biomarker and imaging study-2 investigators. Effects of the direct lipoprotein-associated phospholipase a(2) inhibitor darapladib on human coronary atherosclerotic plaque","volume":"118","author":"Serruys","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0815","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0025-6196(11)60992-0","article-title":"Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review","volume":"82","author":"Garza","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cca.2015.10.021_bb0820","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0825","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0830","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.107.161042","article-title":"HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production","volume":"28","author":"Tolle","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0835","doi-asserted-by":"crossref","first-page":"37457","DOI":"10.1074\/jbc.M605823200","article-title":"Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells","volume":"281","author":"Kimura","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0840","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1074\/mcp.M600326-MCP200","article-title":"Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC\u2013MS\/MS and probabilistic peptide scoring","volume":"6","author":"Heller","year":"2007","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.cca.2015.10.021_bb0845","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the anti-inflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb0850","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2005.03.005","article-title":"Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?","volume":"1","author":"Rader","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2015.10.021_bb0855","first-page":"169","article-title":"Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro","volume":"49","author":"Strunk","year":"1983","journal-title":"Immunology"},{"key":"10.1016\/j.cca.2015.10.021_bb0860","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1161\/01.ATV.20.10.2267","article-title":"Expression of human apolipoprotein A-I\/C-III\/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis","volume":"20","author":"Vergnes","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0865","doi-asserted-by":"crossref","first-page":"31900","DOI":"10.1074\/jbc.M202993200","article-title":"Regulated expression of the apolipoprotein E\/C-I\/C-IV\/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta","volume":"277","author":"Mak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0870","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/CIRCULATIONAHA.108.770669","article-title":"Combined statin and niacin therapy remodels the high-density lipoprotein proteome","volume":"118","author":"Green","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb0875","doi-asserted-by":"crossref","first-page":"36596","DOI":"10.1074\/jbc.M006924200","article-title":"High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI","volume":"275","author":"Yancey","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0880","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1074\/jbc.270.11.5882","article-title":"The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol","volume":"270","author":"Davidson","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0885","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1021\/bi8014746","article-title":"Correlation of structural stability with functional remodeling of high-density lipoproteins: the importance of being disordered","volume":"47","author":"Guha","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2015.10.021_bb0890","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1194\/jlr.M800106-JLR200","article-title":"Effects of acyl chain length, unsaturation, and pH on thermal stability of model discoidal HDLs","volume":"49","author":"Guha","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0895","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.metabol.2006.09.021","article-title":"Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high density lipoproteins","volume":"56","author":"Marmillot","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2015.10.021_bb0900","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1139\/o2012-015","article-title":"Tweaking the cholesterol efflux capacity of reconstituted HDL","volume":"90","author":"Ma","year":"2012","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0905","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-2275(20)33434-9","article-title":"Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression","volume":"41","author":"Baker","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0910","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-2275(20)33375-7","article-title":"Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells","volume":"40","author":"Baker","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0915","doi-asserted-by":"crossref","first-page":"33143","DOI":"10.1074\/jbc.274.46.33143","article-title":"High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL","volume":"274","author":"Xia","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0920","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imbio.2011.07.030","article-title":"High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation","volume":"217","author":"Perrin-Cocon","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.cca.2015.10.021_bb0925","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/bi00216a001","article-title":"Packing characteristics of highly unsaturated bilayer lipids: Raman spectroscopic studies of multilamellar phosphatidylcholine dispersions","volume":"30","author":"Litman","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2015.10.021_bb0930","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.107.161042","article-title":"HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production","volume":"28","author":"Tolle","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0935","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCRESAHA.110.235028","article-title":"Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte\/macrophages in inflammation and atherosclerosis","volume":"108","author":"Keul","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb0940","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","article-title":"Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities","volume":"21","author":"Kontush","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2015.10.021_bb0945","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2005.03.001","article-title":"A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity","volume":"182","author":"Kontush","year":"2005","journal-title":"Atherosclersis"},{"key":"10.1016\/j.cca.2015.10.021_bb0950","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00125-004-1655-5","article-title":"Defective antioxidative activity of small, dense HDL particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycemia","volume":"48","author":"Nobecourt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2015.10.021_bb0955","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"Hansel","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2015.10.021_bb0960","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.atherosclerosis.2004.07.011","article-title":"Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women","volume":"177","author":"Zago","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2015.10.021_bb0965","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2015.10.021_bb0970","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1021\/bi992902m","article-title":"The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study","volume":"39","author":"Curtiss","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2015.10.021_bb0975","doi-asserted-by":"crossref","first-page":"26910","DOI":"10.1074\/jbc.270.45.26910","article-title":"Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability","volume":"270","author":"Sparks","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb0980","first-page":"1200","article-title":"Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function","volume":"2012","author":"Kar","year":"1821","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2015.10.021_bb0985","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis","volume":"29","author":"Zerrad-Saadi","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb0990","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cca.2015.10.021_bb0995","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cca.2015.10.021_bb1000","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/cvr\/cvu140","article-title":"Micro-RNAs and HDL life cycle","volume":"103","author":"Canfran-Duque","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1005","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/nar\/gkm1113","article-title":"Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver","volume":"36","author":"Elmen","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2015.10.021_bb1015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.3200","article-title":"MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion","volume":"19","author":"Soh","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb1020","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cca.2015.10.021_bb1025","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cca.2015.10.021_bb1030","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"D\u00e1valos","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.10.021_bb1035","doi-asserted-by":"crossref","first-page":"33652","DOI":"10.1074\/jbc.M110.152090","article-title":"Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation","volume":"285","author":"Gerin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb1040","doi-asserted-by":"crossref","first-page":"12228","DOI":"10.1073\/pnas.1005191107","article-title":"miR-33 links SREBP-2 induction to repression of sterol transporters","volume":"107","author":"Marquart","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.10.021_bb1045","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cca.2015.10.021_bb1050","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/emmm.201201228","article-title":"miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity","volume":"4","author":"Allen","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb1055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"Rayner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cca.2015.10.021_bb1060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/scitranslmed.3006840","article-title":"Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR","volume":"5","author":"Rottiers","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb1065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.003376","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE\u2212\/\u2212 mice","volume":"1","author":"Horie","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2015.10.021_bb1070","doi-asserted-by":"crossref","first-page":"14518","DOI":"10.1073\/pnas.1215767111","article-title":"MicroRNA-223 coordinates cholesterol homeostasis","volume":"111","author":"Vickers","year":"2014","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.cca.2015.10.021_bb1075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3949\/ccjm.74.10.697","article-title":"The two faces of the \u2018good\u2019 cholesterol","volume":"74","author":"Ansell","year":"2007","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb1080","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2337\/db11-0378","article-title":"Anti-inflammatory and antioxidant properties of HDLs are impaired in Type 2 Diabetes","volume":"60","author":"Morgantini","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2015.10.021_bb1085","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high density lipoprotein cholesterol levels and are favourably affected by simvastatin treatment","volume":"108","author":"Ansell","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb1090","doi-asserted-by":"crossref","first-page":"481437","DOI":"10.1155\/2013\/481437","article-title":"Paired measurements of Paraoxonase 1 and Serum Amyloid A as useful disease markers","volume":"2013","author":"Kotani","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cca.2015.10.021_bb1095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.cca.2015.10.021_bb1100","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1194\/jlr.P002816","article-title":"Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database","volume":"51","author":"Barter","year":"2010","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.cca.2015.10.021_bb1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2015.10.021_bb1110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(02)00047-8","article-title":"Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL","volume":"3","author":"Angelin","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.cca.2015.10.021_bb1115","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI114558","article-title":"Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit","volume":"85","author":"Badimon","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb1120","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0022-2275(20)32212-4","article-title":"Intravenous apoA-I\/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans","volume":"42","author":"Nanjee","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1125","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.jacc.2009.12.067","article-title":"A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome","volume":"55","author":"Waksman","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2015.10.021_bb1130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1194\/jlr.M800622-JLR200","article-title":"Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo","volume":"50","author":"Sacks","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1135","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-I Milano mutant. The Limone sul Garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb1140","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1016\/S0021-9258(17)39238-4","article-title":"Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine","volume":"260","author":"Anantharamaiah","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2015.10.021_bb1145","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0076-6879(86)28096-9","article-title":"Synthetic peptide analogs of apolipoproteins","volume":"128","author":"Anantharamaiah","year":"1986","journal-title":"Methods Enzymol."},{"issue":"3","key":"10.1016\/j.cca.2015.10.021_bb1150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CRD.0b013e3181c4b508","article-title":"Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis","volume":"18","author":"Sherman","year":"2010","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.cca.2015.10.021_bb1155","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/01.ATV.0000165694.39518.95","article-title":"Apolipoprotein A-I mimetic peptides","volume":"25","author":"Navab","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2015.10.021_bb1160","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1194\/jlr.M700552-JLR200","article-title":"Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties","volume":"49","author":"Wool","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1165","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/hc0302.103711","article-title":"Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol","volume":"105","author":"Navab","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb1170","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1194\/jlr.P800003-JLR200","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients","volume":"49","author":"Bloedon","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1175","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/01.CIR.0000134275.90823.87","article-title":"Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice","volume":"109","author":"Navab","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb1180","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.RES.0000190634.60042.cb","article-title":"Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor\/apolipoprotein A-I double-knockout mice on Western diet","volume":"97","author":"Ou","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1185","first-page":"1042","article-title":"Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans","volume":"119","author":"Edmondson","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2015.10.021_bb1190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1194\/jlr.M700399-JLR200","article-title":"Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population","volume":"49","author":"Tang","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic variant of the scavenger receptor BI in humans","volume":"364","author":"Vergeer","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2015.10.021_bb1200","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cca.2015.10.021_bb1205","first-page":"S1175","article-title":"Lecithin cholesterol acyltransferase promotes reverse cholesterol transport and attenuates atherosclerosis progression in New Zealand white rabbits","volume":"120","author":"Zhou","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.10.021_bb1210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/jpet.110.169540","article-title":"Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice","volume":"335","author":"Rousset","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cca.2015.10.021_bb1215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11883-011-0171-6","article-title":"Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?","volume":"13","author":"Rousset","year":"2011","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.cca.2015.10.021_bb1220","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.10.021_bb1225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.plipres.2010.03.002","article-title":"The liver X receptor: control of cellular lipid homeostasis and beyond: implications for drug design","volume":"49","author":"Oosterveer","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cca.2015.10.021_bb1230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2010.07.002","article-title":"Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis","volume":"12","author":"Lo Sasso","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2015.10.021_bb1235","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.jacc.2010.02.035","article-title":"RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo","volume":"55","author":"Bailey","year":"2010","journal-title":"JACC"},{"key":"10.1016\/j.cca.2015.10.021_bb1240","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/biology4030494","article-title":"The regulation of reverse cholesterol transport and cellular cholesterol homeostasis by microRNAs","volume":"4","author":"DiMarco","year":"2015","journal-title":"Biology"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115300243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115300243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:57:40Z","timestamp":1653440260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898115300243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":248,"alternative-id":["S0009898115300243"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.10.021","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL\u2014A molecule with a multi-faceted role in coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}